Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranolazine NDC 69844-025 by Graviti Pharmaceuticals Private Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - bfee8334 acfd 42a4 ad2a 9e1ad2588f3d 01
image - bfee8334 acfd 42a4 ad2a 9e1ad2588f3d 02
This is a medication description for Ranolazine Extended-Release tablets. Each tablet contains 500mg of ranolazine and should be swallowed whole, not crushed or chewed. The usual dosage is found in the package insert. These tablets should be stored at 20°C to 25°C. The medication is manufactured by Graviti Pharmaceuticals Pvt in Telangana, India and distributed by a company based in Wilmington, USA. The batch number is not provided.*
image - bfee8334 acfd 42a4 ad2a 9e1ad2588f3d 03
Ranolazine Extended-Release Tablets are prescription medication and each tablet contains 1000 mg of Ranolazine. The usual dosage is mentioned in the package insert for dosage and administration. The tablets should not be crushed, chewed or broken but swallowed whole. This batch contains 20 grey colored tablets and the package is child-resistant. The tablets should be stored at controlled room temperature. The medication is manufactured for Grayiti Pharmaceuticals Inc. in Delaware USA and manufactured by Grayiti Pharmaceuticals Pvt. Ltd located in Telangana, India.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.